{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T09:01:30Z","timestamp":1766048490459},"reference-count":25,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.3892\/mmr.2014.2154","type":"journal-article","created":{"date-parts":[[2014,4,15]],"date-time":"2014-04-15T08:43:33Z","timestamp":1397551413000},"page":"491-495","source":"Crossref","is-referenced-by-count":20,"title":["Ocular albinism type 1-induced melanoma cell migration is mediated through the RAS\/RAF\/MEK\/ERK signaling pathway"],"prefix":"10.3892","volume":"10","author":[{"given":"JUN","family":"BAI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XIN","family":"XIE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUN","family":"LEI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GAILI","family":"AN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LI","family":"HE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XIAOPENG","family":"LV","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2014,4,15]]},"reference":[{"key":"key20180108010848_b1-mmr-10-01-0491","first-page":"49","article-title":"Molecular targeted therapies in metastatic melanoma","volume":"6","author":"Chakraborty","year":"2013","journal-title":"Pharmgenomics Pers Med"},{"key":"key20180108010848_b2-mmr-10-01-0491","doi-asserted-by":"crossref","first-page":"647684","DOI":"10.1155\/2012\/647684","article-title":"Metastatic behavior in melanoma: timing, pattern, survival, and influencing factors","volume":"2012","author":"Tas","year":"2012","journal-title":"J Oncol"},{"key":"key20180108010848_b3-mmr-10-01-0491","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1101\/gad.191999.112","article-title":"Melanoma: from mutations to medicine","volume":"26","author":"Tsao","year":"2012","journal-title":"Gene Dev"},{"key":"key20180108010848_b4-mmr-10-01-0491","doi-asserted-by":"crossref","first-page":"6561","DOI":"10.1158\/0008-5472.CAN-11-1432","article-title":"PAR-1 and thrombin: the ties that bind the microenvironment to melanoma metastasis","volume":"71","author":"Zigler","year":"2011","journal-title":"Cancer Res"},{"key":"key20180108010848_b5-mmr-10-01-0491","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1096\/fj.10-154757","article-title":"The melanoma-associated transmembrane glycoprotein Gpnmb controls trafficking of cellular debris for degradation and is essential for tissue repair","volume":"24","author":"Li","year":"2010","journal-title":"FASEB J"},{"key":"key20180108010848_b6-mmr-10-01-0491","doi-asserted-by":"crossref","first-page":"6217","DOI":"10.1158\/0008-5472.CAN-12-0402","article-title":"Raf kinase inhibitor RKIP inhibits MDA-9\/syntenin-mediated metastasis in melanoma","volume":"72","author":"Das","year":"2012","journal-title":"Cancer Res"},{"key":"key20180108010848_b7-mmr-10-01-0491","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1600-0625.2009.00846.x","article-title":"Pigmentation-related genes and their implication in malignant melanoma susceptibility","volume":"18","author":"Fernandez","year":"2009","journal-title":"Exp Dermatol"},{"key":"key20180108010848_b8-mmr-10-01-0491","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.biocel.2010.03.023","article-title":"Signaling pathways in melanosome biogenesis and pathology","volume":"42","author":"Schiaffino","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"key20180108010848_b9-mmr-10-01-0491","doi-asserted-by":"crossref","first-page":"11906","DOI":"10.1073\/pnas.1103381108","article-title":"The ocular albinism type 1 (OA1) GPCR is ubiquitinated and its traffic requires endosomal sorting complex responsible for transport (ESCRT) function","volume":"108","author":"Giordano","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108010848_b10-mmr-10-01-0491","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1093\/hmg\/ddn241","article-title":"The ocular albinism type 1 protein, an intracellular G protein-coupled receptor, regulates melanosome transport in pigment cells","volume":"17","author":"Palmisano","year":"2008","journal-title":"Hum Mol Genet"},{"key":"key20180108010848_b11-mmr-10-01-0491","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1038\/sj.onc.1210422","article-title":"Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer","volume":"26","author":"Roberts","year":"2007","journal-title":"Oncogene"},{"key":"key20180108010848_b12-mmr-10-01-0491","first-page":"511","article-title":"The Ras-Raf-MEK-ERK pathway in the treatment of cancer","volume":"25","author":"Hilger","year":"2003","journal-title":"Onkologie"},{"key":"key20180108010848_b13-mmr-10-01-0491","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0092-8674(95)90401-8","article-title":"Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation","volume":"80","author":"Marshall","year":"1995","journal-title":"Cell"},{"key":"key20180108010848_b14-mmr-10-01-0491","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3233\/CBM-2011-0164","article-title":"The molecular pathology of cutaneous melanoma","volume":"9","author":"Bogenrieder","year":"2011","journal-title":"Cancer Biomark"},{"key":"key20180108010848_b15-mmr-10-01-0491","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1365-2133.2012.11125.x","article-title":"Melanoma incidence and mortality in Europe: new estimates, persistent disparities","volume":"167","author":"Forsea","year":"2012","journal-title":"Br J Dermatol"},{"key":"key20180108010848_b16-mmr-10-01-0491","first-page":"488","article-title":"Treatment of metastatic melanoma: an overview","volume":"23","author":"Bhatia","year":"2009","journal-title":"Oncology (Williston Park)"},{"key":"key20180108010848_b17-mmr-10-01-0491","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nm0897-917","article-title":"A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma","volume":"3","author":"Ambrosini","year":"1997","journal-title":"Nat Med"},{"key":"key20180108010848_b18-mmr-10-01-0491","doi-asserted-by":"crossref","first-page":"7927","DOI":"10.1158\/0008-5472.CAN-10-0194","article-title":"Survivin enhances motility of melanoma cells by supporting Akt activation and alpha5 integrin upregulation","volume":"70","author":"McKenzie","year":"2010","journal-title":"Cancer Res"},{"key":"key20180108010848_b19-mmr-10-01-0491","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00210-011-0646-6","article-title":"Protein-protein interactions: a mechanism regulating the anti-metastatic properties of Nm23-H1","volume":"384","author":"Marino","year":"2011","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"key20180108010848_b20-mmr-10-01-0491","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"key20180108010848_b21-mmr-10-01-0491","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0898-6568(02)00007-4","article-title":"Modulation of the Ras\/Raf\/MEK\/ERK pathway by Ca2+, and Calmodulin","volume":"14","author":"Agell","year":"2002","journal-title":"Cell Signal"},{"key":"key20180108010848_b22-mmr-10-01-0491","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/sj.leu.2402945","article-title":"Signal transduction mediated by the Ras\/Raf\/MEK\/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention","volume":"17","author":"Chang","year":"2003","journal-title":"Leukemia"},{"key":"key20180108010848_b23-mmr-10-01-0491","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1158\/0008-5472.CAN-05-0808","article-title":"The Raf inhibitor BAY 43\u20139006 (Sorafenib) induces caspase-independent apoptosis in melanoma cells","volume":"66","author":"Panka","year":"2006","journal-title":"Cancer Res"},{"key":"key20180108010848_b24-mmr-10-01-0491","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.2174\/1381612043384439","article-title":"MEK inhibitors: a therapeutic approach to targeting the Ras-MAP kinase pathway in tumors","volume":"10","author":"Sebolt-Leopold","year":"2004","journal-title":"Curr Pharm Des"},{"key":"key20180108010848_b25-mmr-10-01-0491","first-page":"5198","article-title":"Suppression of BRAF(V599E) in human melanoma abrogates transformation","volume":"63","author":"Hingorani","year":"2003","journal-title":"Cancer Res"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2014.2154\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T21:37:01Z","timestamp":1515361021000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2014.2154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,15]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,4,15]]},"published-print":{"date-parts":[[2014,7]]}},"alternative-id":["10.3892\/mmr.2014.2154"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2014.2154","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,15]]}}}